Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer

Annals of Surgical Oncology

Volumn 12, Issue 3, 2005, Pages 214-221

  White, Rebekah R ^a   Xie, H Bill ^a   Gottfried, Marcia R ^a   Czito, Brian G ^a   Hurwitz, Herbert I ^a   Morse, Michael A ^a   Blobe, Gerald C ^a   Paulson, Erik K ^a   Baillie, John ^a   Branch, M Stanley ^a   Jowell, Paul S ^a   Clary, Bryan M ^a   Pappas, Theodore N ^a   Tyler, Douglas S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemoradiotherapy; Histological response; Neoadjuvant therapy; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; FEMALE; FIBROSIS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PREOPERATIVE TREATMENT; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TUMOR DIFFERENTIATION; TUMOR NECROSIS;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20244385572     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2005.03.105     Document Type: Article

References (23)

1. TA Sohn CJ Yeo JL Cameron 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 567 79
2. MH Kalser SS Ellenberg 1985 Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 899 903
3. JH Klinkenbijl J Jeekel T Sahmoud 1999 Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 776 82
4. JP Neoptolemos JA Dunn DD Stocken 2001 Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 358 1576 85
5. F Spitz J Abruzzese J Lee 1997 Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 928 37
6. SG Swisher JA Ajani R Komaki 2003 Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer Int J Radiat Oncol Biol Phys 57 120 7
7. AM Lowy PF Mansfield SD Leach R Pazdur P Dumas JA Ajani 1999 Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer Ann Surg 229 303 8
8. NA Janjan J Abbruzzese R Pazdur 1999 Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer Radiother Oncol 51 153 60
9. MW Onaitis RB Noone R Fields 2001 Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival Ann Surg Oncol 8 801 6
10. JP Hoffman S Lipsitz T Pisansky JL Weese L Solin AB Benson III 1998 Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group study J Clin Oncol 16 317 23
11. R White H Hurwitz C Lee 2001 Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Oncol 8 758 65
12. CA Iacobuzio-Donahue B Ryu RH Hruban SE Kern 2002 Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion Am J Pathol 160 91 9
13. TW Yen NP Aardal MP Bronner 2002 Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas Surgery 131 129 34
14. Y Shimosato S Oboshi K Baba 1971 Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas Jpn J Clin Oncol 1 19 35
15. DB Evans TA Rich DR Byrd 1992 Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 1335 9
16. TM Breslin KR Hess DB Harbison 2001 Neoadjuvant chemoradiation for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol 8 123 32
17. RR White EK Paulson K Freed 2001 Staging of pancreatic cancer before and after neoadjuvant chemoradiation J Gastrointest Surg 5 626 33
18. HA Burris III MJ Moore J Andersen 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403 13
19. Y Sato Y Nio MM Song 1997 p53 protein expression as prognostic factor in human pancreatic cancer Anticancer Res 17 2779 88
20. M Mohiuddin D Chendil S Dey RA Alcock W Regine MM Ahmed 2002 Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells Anticancer Res 22 825 30
21. M Dong Y Nio K Yamasawa T Toga L Yue T Harada 2003 p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer J Surg Oncol 82 111 20
22. K Uegaki Y Nio Y Inoue 1997 Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer Anticancer Res 17 3841 7
23. HQ Xiong JL Abbruzzese 2002 Epidermal growth factor receptor-targeted therapy for pancreatic cancer Semin Oncol 29 5 (Suppl) 14 31 7